According to a recent review study published in the Current Pain and Headache Reports journal, the behavioral pattern of a person is significantly linked with episodic migraine attacks and related disability. An episodic migraine involves 0 to 14 migraine attacks per month. How an individual behavior triggers or intensifies an episodic migraine is still under review.
As per recent research conducted in the Department of Anesthesiology and Intensive Care Medicine, Lovran, Croatia, the postoperative regional analgesia helps to maintain cell-mediated immunity and perforin expression in peripheral blood lymphocytes in patients after Total knee replacement (TKR).
A recent study has found that abatacept can reduce synovial regulatory T-cell expression (Treg) in patients with psoriatic arthritis (PsA) and thus, can be considered as an effective treatment option for joint pain.
A new monoclonal antibody, Erenumab was found efficacious in reducing migraine attacks and medication overuse. A migraine is counted as the 3rd most prevalent disease throughout the world. Many people suffered from a headache are used to take more and more painkillers. The problem of medication overuse may soon cease with the help of an antibody; an antibody reduces the count of migraine attacks.
Anti-retroviral therapy has led to a significant decline in mortality of individuals infected with human immunodeficiency virus (HIV). According to latest HIV treatment guidelines, antiretroviral treatment (ART) should be initiated at the time of diagnosis. A recent study has revealed that early ART can cause more significant bone loss compared with deferring ART.
This study followed 399 participants (195 received immediate ART and 204 deferred ART) for an average of 2.2 years.
The study determined an adverse effect on bone density in patients on immediate ART. But the overall benefits of ART for preventing HIV transmission and adverse health outcomes outweighs this adverse effects.
- 1 of 179